Form 4 holding
Chief Scientific Officer
Kronos Bio, Inc.
- Security class
- Common Stock
- Shares / value
- 234,603
- Estimated value
- $247,248
- Report date
- 21 Feb 2024
- Price
- $1.05
- Ownership
- Direct
Charles Y. Lin
Insider Reports History
- Reporting-owner location
- San Mateo, CA
- Latest reporting-owner signature
-
/s/ Allison Frisbee, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Charles Y. Lin
Form 4 holding
Chief Scientific Officer
Kronos Bio, Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 72,900
- Estimated value
- Report date
- 15 Oct 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Charles Y. Lin
4
KRON
Kronos Bio, Inc.
- Report period
- 15 Oct 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 15 Oct 2024, 18:55
- Role
- Chief Scientific Officer
- Next action
- Open filing details
4
KRON
Kronos Bio, Inc.
- Report period
- 21 Feb 2024
- Transactions
- 1
- Transaction value
- -$12,685
- Accepted by SEC
- 23 Feb 2024, 20:07
- Role
- SR VP, RESEARCH & DEVELOPMENT
- Next action
- Open filing details
3
KRON
Kronos Bio, Inc.
- Report period
- 16 Feb 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 23 Feb 2024, 20:06
- Role
- SR VP, RESEARCH & DEVELOPMENT
- Next action
- Open filing details